Haemophilia B Curative FIX Production from a Low Dose UCOE-based Lentiviral Vector Following Hepatic Pre-natal Delivery

E-ISSN： 1875-5631|16|4|231-241

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.16, Iss.4, 2016-12, pp. : 231-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Codon Swapping of Zinc Finger Nucleases Confers Expression in Primary Cells and In Vivo from a Single Lentiviral Vector

Current Gene Therapy, Vol. 14, Iss. 5, 2014-10 ,pp. : 365-376

Bentham Science Publishers

Access to resources Recommend Favorite

Lentiviral Delivery of Proteins for Genome Engineering

Current Gene Therapy, Vol. 16, Iss. 3, 2016-06 ,pp. : 194-206

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Primate EIAV-Based Lentiviral Vectors as Gene Delivery System for Motor Neuron Diseases

Current Gene Therapy, Vol. 4, Iss. 3, 2004-09 ,pp. : 277-286

Bentham Science Publishers

Access to resources Recommend Favorite

Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS ( R)), with commercial lipid-based formulations

By Fukui H. Koike T. Nakagawa T. Saheki A. Sonoke S. Tomii Y. Seki J.

International Journal of Pharmaceutics, Vol. 267, Iss. 1, 2003-11 ,pp. : 101-112

Elsevier

Access to resources Recommend Favorite

Haemophilia B: Christmas disease

By Giangrande Paul

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1517-1524

Informa Healthcare

Access to resources Recommend Favorite